PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease
EORTC at ISCB 40, Annual Conference of the International Society for Clinical Biostatistics
Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report (2019 - Journal of Thoracic Oncology)
Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy (2019 - British Journal of Radiology, The)
The EORTC Cancer Research Fund aims to raise funds to support the independent academic cancer research activities of the EORTC.
The EORTC invites you to support the manifesto on Treatment Optimisation. Please confirm your support before the 28th Feb. 2019.